The IPO Buzz: Windward Bio (WWB Proposed) Sets Terms for $175 Million IPO
Windward Bio (WWB Proposed), a Swiss biotech developing long-acting drug candidates to treat asthma, COPD and atopic dermatitis, unveiled the terms early today (Monday, Nov. 9,2026) for its $175 million IPO. Windward Bio is offering 10.29 million shares at a price range of $16.00 to $18.00 to raise $174.93 million, if priced at the $17.00 mid-point of its range, according to its F-1/A filing date..
Read more November 9, 2026IPO Calendar
| Company | Symbol proposed | Shares (Millions) | Est. $ Volume | Expected to Trade | SCOOP Rating | Rating Change |
|---|---|---|---|---|---|---|
| Rezera Inc. | RZRA | 16.7 | $ 200.0 mil | 11/12/2026 Thursday | S/O | S/O |
| Windward Bio Group AG | WWB | 10.3 | $ 174.9 mil | 11/13/2026 Friday | S/O | S/O |
| Primagrove | YNTE | 6.3 | $ 30.5 mil | 11/16/2026 Week of | S/O | S/O |
Last 100 IPOs - November 8, 2026
| Number of IPOs priced : | 100 |
| Number Up: | 42 |
| Number Down: | 56 |
| Number Unchanged: | 2 |
| Percentage Change From Issue Price: | -0.01% |
| Percentage Change for The Nasdaq Composite | 35.22% |
2026 IPO Scorecard - November 8, 2026
| Number of IPOs priced (Excluding 154 units) : | 138 |
| Number Up: | 53 |
| Number Down: | 83 |
| Number Unchanged: | 2 |
| Total Return From Issue Price: | -1.55% |
| The Nasdaq Composite Index YTD % Change | 35.22% |